Ultrasound Assessment During Weaning from Mechanical Ventilation
Launched by HOSPITAL ITALIANO DE BUENOS AIRES · Sep 19, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is a multicenter, prospective, observational trial to develop an ultrasound-based predictive model for extubation failure in mechanically ventilated ICU patients. Extubation failure, defined as re-intubation or death within 48 hours post-extubation, remains a significant challenge, occurring in 15-35% of cases. Prolonged mechanical ventilation is associated with increased morbidity, infection risk, and hospital costs. Traditional predictors, such as maximal inspiratory pressure (Pimax), rapid shallow breathing index (RSBI or Tobin index), and other clinical parameters, have shown...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (18 years or older).
- • Receiving mechanical ventilatory assistance for more than 48 hours.
- • The patient is deemed ready to undergo a Spontaneous Breathing Trial, as determined by the attending physician.
- • Ultrasound measurements are performed between 20 and 30 minutes after the initiation of the trial.
- Exclusion Criteria:
- • Patients with known or diagnosed neuromuscular disease.
- • Limitation of therapeutic effort
- • History of severe valvulopathy, severe coronary artery disease, known left ventricular ejection fraction \<35%, or known grade 3 diastolic dysfunction, or who are considered candidates for tracheostomy due to their severity.
- • History of home ventilatory support
- • Patients who do not have a good acoustic window or have any type of limitation to perform pulmonary, cardiac, or diaphragmatic ultrasound.
- • Patients who at the discretion of the treating medical team cannot be placed on a T-tube.
About Hospital Italiano De Buenos Aires
Hospital Italiano de Buenos Aires is a leading healthcare institution dedicated to advancing medical research and patient care. Renowned for its commitment to clinical excellence and innovation, the hospital actively participates in a range of clinical trials aimed at developing new treatment modalities and improving healthcare outcomes. With a multidisciplinary team of experienced healthcare professionals, Hospital Italiano combines cutting-edge technology with a patient-centered approach, ensuring the highest standards of safety and efficacy in all research endeavors. As a trusted sponsor, the hospital is committed to contributing to the global medical community through rigorous scientific investigations and collaboration with various stakeholders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Buenos Aires, Capital Federal, Argentina
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported